Skip to main content
Egyptian Rheumatology and Rehabilitation

Table 1 Descriptive and clinical data of the studied cases before receiving biologic treatment

From: Role of serum survivin as a predictor of response to biological treatment in rheumatoid arthritis patients

Variable

Mean ± SD

Range

Duration of morning stiffness

49.5 ± 17.2 min

30–90

HAQ score

1.6 ± 0.46

0.8–2.3

Number of tender joints

8.4 ± 3.3

4–17

Number of swollen joints

7.1 ± 2.4

3–12

ESR

36.4 ± 12.9

20–70

CRP

9.9 ± 6.2

3.6–23.1

DAS 28

5.6 ± 0.59

4.4–6.9

  1. CRP C-reactive protein, DAS Disease activity score, ESR Erythrocyte sedimentation rate, HAQ Health assessment questionnaire
Back to article page